Advertisement
U.S. Markets closed

Klotho Neurosciences, Inc. (KLTO)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
0.7103-0.0471 (-6.22%)
At close: 04:00PM EDT
0.7100 -0.00 (-0.04%)
After hours: 07:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.7574
Open0.5600
Bid0.4349 x 100
Ask0.4952 x 100
Day's Range0.6601 - 0.8800
52 Week Range0.4050 - 13.1000
Volume690,438
Avg. Volume1,371,192
Market Cap15.103M
Beta (5Y Monthly)-0.00
PE Ratio (TTM)N/A
EPS (TTM)-0.0000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences

    KLTO strengthens team with industry veteran and is poised to accelerate the development of its therapeutic candidatesNEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for aging and age-related diseases, today announced the appointment of Peter Moriarty, Co-Founder of Shire Pharmaceuticals, as its Chief Operating Officer (COO). Dr. Joseph Sinkule, Chairman, CEO, and Founder of Klotho Neurosc

  • GlobeNewswire

    Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)

    Renowned Biotech Leader to Contribute Expertise in Neuroscience and Therapeutics DevelopmentNEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a cutting-edge biotechnology company focused on developing innovative therapies for neurodegenerative diseases and promoting healthy longevity, is proud to announce that Dr. Robert Langer, co-founder of Moderna, has joined its Scientific Advisory Board. In addition to lending his world-class scientific expertise to gui